Page 17 - Crispr News Today

Researchers at the University of Pennsylvania investigated a new, potentially less toxic method that corrects the pathogenic genes at their source.

We can change the flavour and texture of foods like bread and rice wine by tweaking the genomes of the yeasts that are used to make them

InnovationRx is your weekly digest of healthcare news. Sign up!

InnovationRx is your weekly digest of healthcare news. Sign up!

An estimated 145 "height genes" have been discovered that could determine how tall a child will grow.

CAR T therapy has yet to be translated for T cell derived leukemias. One study leaves room for hope, as their CAR T product demonstrates early proof-of-concept.

An influential US drug pricing watchdog raised the price estimate of two experimental gene therapies from Vertex Pharmaceuticals/CRISPR Therapeutics and bluebird bio for sickle cell disease.

According to Coherent Market Insights, global CRISPR technology market is generated $2.25 billion in 2022, and is anticipated to generate $7.72 billion by 2030,

Induced pluripotent stem cells (iPSC), a continuing muse in cell therapy research, could potentially be used to improve flaws associated with conventional CAR T therapy.

The world’s first CRISPR therapy may be approved soon, but sadly it is unlikely to be affordable for hundreds of thousands of people whose pain it could end